Abstract
Rapid advances in gene expression microarray technology have enabled to discover molecular markers used for cancer diagnosis, prognosis, and prediction. One computational challenge with using microarray data analysis to create cancer classifiers is how to effectively deal with microarray data which are composed of high-dimensional attributes (p) and low-dimensional instances (n). Gene selection and classifier construction are two key issues concerned with this topics. In this article, we reviewed major methods for computational identification of cancer marker genes based on microarray gene expression data. We concluded that simple methods should be preferred to complicated ones for their interpretability and applicability.
Keywords: Cancer, computational biology, marker genes, microarrays.
Current Bioinformatics
Title:Identification of Marker Genes for Cancer Based on Microarrays Using a Computational Biology Approach
Volume: 9 Issue: 2
Author(s): Xiaosheng Wang
Affiliation:
Keywords: Cancer, computational biology, marker genes, microarrays.
Abstract: Rapid advances in gene expression microarray technology have enabled to discover molecular markers used for cancer diagnosis, prognosis, and prediction. One computational challenge with using microarray data analysis to create cancer classifiers is how to effectively deal with microarray data which are composed of high-dimensional attributes (p) and low-dimensional instances (n). Gene selection and classifier construction are two key issues concerned with this topics. In this article, we reviewed major methods for computational identification of cancer marker genes based on microarray gene expression data. We concluded that simple methods should be preferred to complicated ones for their interpretability and applicability.
Export Options
About this article
Cite this article as:
Wang Xiaosheng, Identification of Marker Genes for Cancer Based on Microarrays Using a Computational Biology Approach, Current Bioinformatics 2014; 9 (2) . https://dx.doi.org/10.2174/1574893608999140109115649
DOI https://dx.doi.org/10.2174/1574893608999140109115649 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Generation of Oncolytic Herpes Virus
Current Cancer Therapy Reviews Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Systemic Treatment of Chest Tumors: Highlighting Some Differences Between Eastern and Western Countries
Current Cancer Therapy Reviews Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Recent Patents on Anti-Cancer Drug Discovery State of Research Tracks and Property Protection of Photodynamic Sensitizers and Delivery Methodologies
Recent Patents on Chemical Engineering Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry
Current Medicinal Chemistry Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells
Current Cancer Drug Targets Analysis of Hypoxiamir-Gene Regulatory Network Identifies Critical MiRNAs Influencing Cell-Cycle Regulation Under Hypoxic Conditions
MicroRNA Use of Anti-Cancer Drugs, Mitocans, to Enhance the Immune Responses against Tumors
Current Pharmaceutical Biotechnology Transferrin and the Transferrin Receptor: Of Magic Bullets and Other Concerns
Inflammation & Allergy - Drug Targets (Discontinued) MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
Current Gene Therapy Nanomedicine: A New Frontier in Cancer Therapeutics
Current Drug Delivery Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells
Current Drug Targets Platinum Formulations as Anticancer Drugs Clinical and Pre-Clinical Studies
Current Topics in Medicinal Chemistry Comparative Proteomics and Bioinformatics Analysis of Tissue from Non-Small Cell Lung Cancer Patients
Current Proteomics The Potential of Desirability Function Strategy in Chemometric Optimization of ICP-AES for Platinum Group Elements and Gold
Current Analytical Chemistry Recent Advances in Small Molecule Prodrugs for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy
Current Pharmaceutical Design